| URL | Priority | Change frequency | Last modified (GMT) |
|---|---|---|---|
| https://alzheon.com/alzheon-says-data-backs-potential-of-alzheimers-candidate/ | 60% | Monthly | 2019-09-23 16:10 |
| https://alzheon.com/clinical-effects-tramiprosate-apoe44-homozygous-patients-mild-alzheimers-disease-suggest-disease-modification-potential/ | 60% | Monthly | 2019-09-23 16:10 |
| https://alzheon.com/alzheon-publishes-new-analyses-showing-clinical-benefit-tramiprosate-apoe44-homozygous-patients-mild-stage-alzheimers-disease-clinical-effects-suggest-disease-modification-p/ | 60% | Monthly | 2019-09-23 16:10 |
| https://alzheon.com/insights-discovery-clinical-efficacy-support-new-class-therapeutics-alzheimers-disease/ | 60% | Monthly | 2019-09-23 16:10 |